Metastatic Esophageal Adenocarcinoma Showing 68 Ga-DOTATATE Uptake.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 37756476.
- Also identified by DOI 10.1097/RLU.0000000000004844.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of 68 Ga-DOTATATE PET/CT in the evaluation of neuroendocrine tumors is well defined. Nevertheless, 68 Ga-DOTATATE uptake may be seen in some tumors other than neuroendocrine tumors as a reflection of tumor blood supply and somatostatin receptor expression. Although 68 Ga-DOTATATE uptake has been described in a number of nonneuroendocrine tumors, no case of 68 Ga-DOTATATE uptake in esophagus adenocarcinoma has been reported. We present the case of a 52-year-old man who had a metastatic esophageal adenocarcinoma showing 68 Ga-DOTATATE uptake.
Medical subject headings
- Esophageal Neoplasms
- Adenocarcinoma
- Neuroendocrine Tumors
- Organometallic Compounds